References
- Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95:E131–E1e4.
- Zhao Y, Nie HX, Hu K, et al. Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty. 2020;9:108.
- Tavakolpour S, Rakhshandehroo T, Wei EX, et al. Lymphopenia during the COVID-19 infection: what it shows and what can be learned. Immunol Lett. 2020;225:31–32.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
- Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China. Clin Infect Dis. 2020;71:762–768.
- Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in wenzhou, China. Clin Chim Acta. 2020;507:174–180.
- Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in wuhan, China. Allergy. 2020;75:1730–1741.
- Ngiam JN, Chew N, Tham SM, et al. Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young, migrant workers with reduced risk of severe disease. Int J Infect Dis. 2021;103:329–335. DOI:https://doi.org/10.1016/j.ijid.2020.11.157.
- Ho JS, Sia CH, Chan MY, et al. Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung. 2020;49:681–685.
- Ho JS, Tambyah PA, Ho AF, et al. Effect of coronavirus infection on the human heart: a scoping review. Eur J Prev Cardiol. 2020;27:1136–1148.
- Ho JSY, Tambyah PA, Sia CH. A call for vaccine against COVID-19: implications for cardiovascular morbidity and healthcare utilization. Cardiovasc Drugs Ther. 2020;34:585–587.
- Fraissé M, Logre E, Mentec H, et al. Eosinophilia in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care. 2020;24(1):635. DOI:https://doi.org/10.1186/s13054-020-03361-z.
- Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J (Engl) 2020;133:1087–1095.
- Wang Z, Ye D, Wang M, et al. Clinical features of COVID-19 patients with different outcomes in wuhan: a retrospective observational study. Biomed Res Int. 2020;2020:2138387.
- Henry B, Cheruiyot I, Vikse J, et al. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis. Acta bio-Medica: Atenei Parmensis. 2020;91(3):e2020008. DOI:https://doi.org/10.23750/abm.v91i3.10217.
- Chen J, Lau YF, Lamirande EW, et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol. 2010;84:1289–1301.
- Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. J Leukoc Biol. 2020;108:377–396. DOI:https://doi.org/10.1002/JLB.4MIR0220-574RR.
- Wang J, Li Q, Yin Y, et al. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Front Immunol. 2020;11:2063. DOI:https://doi.org/10.3389/fimmu.2020.02063.
- Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999. DOI:https://doi.org/10.1172/jci.insight.138999.
- Lissoni P, Rovelli F, Monzon A, et al. Evidence of abnormally low lymphocyte-to-monocyte ratio in COVID-19-induced severe acute respiratory syndrome. Journal of Immunology and Allergy. 2020;1. DOI:https://doi.org/10.37191/Mapsci-2582-6549-1(2)-011.
- Dinarello CA, Kaplanski G. Interleukin-18 treatment options for inflammatory diseases. Expert Rev Clin Immunol. 2005;1:619–632.
- Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58:1021–1028.
- Ghahramani S, Tabrizi R, Lankarani KB, et al. Laboratory features of severe vs. non-severe COVID-19 patients in asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25(1):30. DOI:https://doi.org/10.1186/s40001-020-00432-3.
- Huang R, Xie L, He J, et al. Association between the peripheral blood eosinophil counts and COVID-19: a meta-analysis. Medicine (Baltimore). 2021;100:e26047.
- Zhu C, Weng QY, Zhou LR, et al. Homeostatic and early-recruited CD101(-) eosinophils suppress endotoxin-induced acute lung injury. Eur Respir J. 2020;56(5):1902354. DOI:https://doi.org/10.1183/13993003.02354-2019.